These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24037753)

  • 1. Endometrial adult/progenitor stem cells: pathogenetic theory and new antiangiogenic approach for endometriosis therapy.
    Pittatore G; Moggio A; Benedetto C; Bussolati B; Revelli A
    Reprod Sci; 2014 Mar; 21(3):296-304. PubMed ID: 24037753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis.
    Moggio A; Pittatore G; Cassoni P; Marchino GL; Revelli A; Bussolati B
    Fertil Steril; 2012 Dec; 98(6):1521-30.e2. PubMed ID: 22981172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis.
    Gargett CE; Schwab KE; Brosens JJ; Puttemans P; Benagiano G; Brosens I
    Mol Hum Reprod; 2014 Jul; 20(7):591-8. PubMed ID: 24674992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
    Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.
    Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F
    Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and antiangiogenic therapy in endometriosis.
    Becker CM; D'Amato RJ
    Microvasc Res; 2007; 74(2-3):121-30. PubMed ID: 17574280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models for anti-angiogenic therapy in endometriosis.
    Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
    J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model.
    Ozcan Cenksoy P; Oktem M; Erdem O; Karakaya C; Cenksoy C; Erdem A; Guner H; Karabacak O
    Gynecol Endocrinol; 2015 Mar; 31(3):219-24. PubMed ID: 25373440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural therapies assessment for the treatment of endometriosis.
    Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
    Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
    Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
    J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial stem/progenitor cells.
    Maruyama T
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2015-22. PubMed ID: 25160689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
    Van Langendonckt A; Donnez J; Defrère S; Dunselman GA; Groothuis PG
    Mol Hum Reprod; 2008 May; 14(5):259-68. PubMed ID: 18430758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats.
    Yildiz C; Kacan T; Akkar OB; Karakus S; Kacan SB; Ozer H; Cetin A
    Reprod Sci; 2015 Nov; 22(11):1445-51. PubMed ID: 25963915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
    Novella-Maestre E; Herraiz S; Vila-Vives JM; Carda C; Ruiz-Sauri A; Pellicer A
    Fertil Steril; 2012 Nov; 98(5):1209-17. PubMed ID: 22921078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells in endometrium and endometriosis.
    Ulukus M
    Womens Health (Lond); 2015 Aug; 11(5):587-95. PubMed ID: 26314416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis.
    García-Pascual CM; Martínez J; Calvo P; Ferrero H; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Pellicer A; Gómez R
    Fertil Steril; 2015 Nov; 104(5):1310-8. PubMed ID: 26297642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regenerating endometrium from stem/progenitor cells: is it abnormal in endometriosis, Asherman's syndrome and infertility?
    Deane JA; Gualano RC; Gargett CE
    Curr Opin Obstet Gynecol; 2013 Jun; 25(3):193-200. PubMed ID: 23562953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.
    Abbas MA; Taha MO; Zihlif MA; Disi AM
    Eur J Pharmacol; 2013 Feb; 702(1-3):12-9. PubMed ID: 23353590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis.
    Tesone M; Bilotas M; Barañao RI; Meresman G
    Gynecol Obstet Invest; 2008; 66 Suppl 1():10-8. PubMed ID: 18936547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
    Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
    J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.